**promotion blocked**.au/companies/news/967499/chimeric-therapeutics-has-coverage-initiated-by-raas-with-mid-case-valuation-of-0-74-per-share-967499.html
(proactive investor URL)
New coverage initiated by RAAS. Note: This valuation is purely for the CLTX asset not CDH17 as it is in pre-clinical until early next year.
Bargain right now..
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.76K | 2.928M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4817793 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18563373 | 21 |
View Market Depth
| Last trade - 14.13pm 26/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |